Publicaciones en las que colabora con MARIA SAINZ GIL (9)

2023

  1. Hydroxychloroquine safety in Covid-19 vs non-Covid-19 patients: analysis of differences and potential interactions

    Expert Opinion on Drug Safety, Vol. 22, Núm. 1, pp. 71-79

2022

  1. Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database

    Drugs - Real World Outcomes, Vol. 9, Núm. 2, pp. 211-218

2020

  1. Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases

    International Journal of Clinical Pharmacy, Vol. 42, Núm. 2, pp. 713-720

2018

  1. Antipsychotics and cardiovascular risk: A case/non-case study

    Psychiatry Research, Vol. 270, pp. 341-347

  2. Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study

    International Journal of Clinical Pharmacy, Vol. 40, Núm. 4, pp. 928-935

2017

  1. Risk excess of mortality and use of antipsychotics: A case-noncase study

    International Clinical Psychopharmacology, Vol. 32, Núm. 1, pp. 1-5

  2. Risk of bursitis and other injuries and dysfunctions of the shoulder following vaccinations

    Vaccine, Vol. 35, Núm. 37, pp. 4870-4876

2016

  1. Impact of regulatory measures on antipsychotics drug consumption in Castilla y León, Spain

    Public Health, Vol. 141, pp. 113-119

2010

  1. Estudio sobre cumplimiento terapéutico de antibióticos en oficinas de farmacia

    Atencion Farmaceutica, Vol. 12, Núm. 4, pp. 247-250